Avantor, Inc. (NYSE:AVTR) Position Lessened by Silvercrest Asset Management Group LLC

Silvercrest Asset Management Group LLC lessened its position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 3.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,006,698 shares of the company's stock after selling 105,059 shares during the quarter. Silvercrest Asset Management Group LLC owned 0.44% of Avantor worth $63,351,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Perpetual Ltd raised its holdings in shares of Avantor by 38.7% during the fourth quarter. Perpetual Ltd now owns 1,766,882 shares of the company's stock worth $37,228,000 after purchasing an additional 493,408 shares during the last quarter. Rhumbline Advisers raised its stake in shares of Avantor by 1.8% during the 4th quarter. Rhumbline Advisers now owns 1,922,368 shares of the company's stock valued at $40,504,000 after buying an additional 33,692 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Avantor by 2.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,027,636 shares of the company's stock valued at $63,792,000 after buying an additional 74,735 shares during the last quarter. Blue Trust Inc. lifted its holdings in shares of Avantor by 6.9% in the 4th quarter. Blue Trust Inc. now owns 8,069 shares of the company's stock valued at $170,000 after buying an additional 522 shares during the period. Finally, Robeco Institutional Asset Management B.V. boosted its stake in shares of Avantor by 38.1% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 119,063 shares of the company's stock worth $2,509,000 after buying an additional 32,838 shares during the last quarter. 95.08% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Gregory L. Summe purchased 25,000 shares of the business's stock in a transaction on Wednesday, May 7th. The shares were bought at an average price of $12.00 per share, with a total value of $300,000.00. Following the completion of the purchase, the director now directly owns 50,000 shares in the company, valued at approximately $600,000. This trade represents a 100.00% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP James Bramwell sold 3,758 shares of the stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $65,877.74. Following the completion of the sale, the executive vice president now directly owns 87,379 shares of the company's stock, valued at $1,531,753.87. The trade was a 4.12% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.20% of the company's stock.

Avantor Stock Performance

Shares of Avantor stock traded down $0.71 during trading on Wednesday, reaching $12.77. The company's stock had a trading volume of 2,575,202 shares, compared to its average volume of 7,821,079. Avantor, Inc. has a fifty-two week low of $11.82 and a fifty-two week high of $28.00. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54. The firm has a market cap of $8.70 billion, a PE ratio of 12.31, a P/E/G ratio of 1.55 and a beta of 1.09. The company has a 50-day moving average price of $14.67 and a two-hundred day moving average price of $18.46.

Avantor (NYSE:AVTR - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $0.23 earnings per share for the quarter, meeting analysts' consensus estimates of $0.23. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.61 billion. Avantor had a net margin of 10.49% and a return on equity of 12.17%. Avantor's quarterly revenue was down 5.9% on a year-over-year basis. During the same period last year, the firm posted $0.22 EPS. On average, analysts forecast that Avantor, Inc. will post 1.06 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on AVTR shares. The Goldman Sachs Group cut Avantor from a "buy" rating to a "neutral" rating and reduced their price target for the company from $23.00 to $14.00 in a research report on Tuesday, April 29th. Wells Fargo & Company cut their price objective on Avantor from $25.00 to $22.00 and set an "overweight" rating for the company in a research note on Thursday, April 17th. Morgan Stanley cut Avantor from an "overweight" rating to an "equal weight" rating in a research note on Tuesday, April 29th. Stifel Nicolaus lowered shares of Avantor from a "buy" rating to a "hold" rating and decreased their price objective for the stock from $26.00 to $14.00 in a report on Monday, April 28th. Finally, Cowen downgraded Avantor from a "buy" rating to a "hold" rating in a research report on Monday, April 28th. Seven equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat, Avantor currently has a consensus rating of "Hold" and a consensus price target of $18.88.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.